Table 1.

Sociodemographic and disease-related characteristics of the study populations [n (%)]

	Breast cancer	Multiple myeloma	Prostate cancer
Number of patients	101	107	66
Study center
CIO Bonn Johanniter Hospital Bonn University Hospital Dresden	80 (79.2) 21 (20.8) 0 (0)	35 (32.7) 12 (11.2) 60 (56.1)	6 (9.1) 0 (0) 60 (90.9)
Gender
Male Female	0 (0) 101 (100)	67 (62.6) 40 (37.4)	66 (100) 0 (0)
Age
Median [years]	58 (IQR: 16, range: 28–84, mean 58.0, SD 11.4)	62 (IQR: 13, range: 33–83, mean: 62.0, SD: 9.1)	76 (IQR: 8, range: 59–94, mean: 74.5, SD: 6.9)
Time since the first diagnosis of cancer
Median [months]	14 (IQR: 67, range: 1–506, mean: 59, SD: 86.9)	59 (IQR: 69, range: 2–255, mean: 63.7, SD: 52.8)	27 (IQR: 60, range: 1–190, mean: 41.7, SD: 43.3)
Current therapy situation
Outpatient therapy Inpatient therapy	101 (100) 0 (0)	87 (81.3) 20 (18.7)	56 (84.9) 10 (15.1)
Current therapy intention
Curative Palliative Other/unknown	32 (31.7) 53 (52.5) 16 (15.8)	35 (32.7) 68 (63.6) 4 (3.7)	24 (36.4) 30 (45.5) 12 (18.2)
Current therapy sequence
Adjuvant Neoadjuvant Other/unknown	52 (51.5) 23 (22.8) 26 (25.7)	n.a. n.a. n.a.	3 (4.5) 0 (0) 63 (95.5)
Current additional therapy modalities*
Radiation Surgery No additional therapy Other/unknown	21 (20.8) 20 (19.8) 60 (59.4) 0 (0)	3 (2.8) 0 (0) 90 (84.1) 14 (13.1)#	29 (43.9) 1 (1.5) 27 (41) 9 (13.6)
Metastases
Patients with metastases Number of metastases per patient with metastases	54 (53.5) 1.7 (SD: 0.9, median: 1, IQR: 1, range: 1–4)	n.a. n.a.	20 (30.3) 1.1 (SD: 0.2, median: 1, IQR: 0, range: 1–2)
Relapses
Patients with relapse	22 (21.8)	27 (25.2)	18 (27.3)

n.a. = not applicable, IQR = interquartile range, SD = standard deviation, * = besides drug therapy, # patients with autologous stem cell transplantation